Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Rain Therapeutics Inc. | rain-ex312_7.htm |
| EX-31.1 - EX-31.1 - Rain Therapeutics Inc. | rain-ex311_6.htm |
| 10-Q - 10-Q - Rain Therapeutics Inc. | rain-10q_20210331.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Rain Therapeutics Inc. (the “Company”) for the period ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
|
1. |
The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act, and |
|
2. |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: May 25, 2021 |
By: |
/s/ Avanish Vellanki |
|
|
|
Avanish Vellanki |
|
|
|
Chairman and Chief Executive Officer (principal executive officer)
|
|
|
|
|
|
Date: May 25, 2021 |
By: |
/s/ Nelson Cabatuan |
|
|
|
Nelson Cabatuan |
|
|
|
Senior Vice President of Finance and Administration (principal financial and accounting officer) |
The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. §1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Note: A signed original of this written statement required by §906 has been provided to Rain Therapeutics Inc. and will be retained by Rain Therapeutics Inc. and furnished to the Securities and Exchange Commission or its staff upon request.